Prevalence of transfusion transmitted virus (TTV) genotypes among HCC patients in Qaluobia governorate
2007

Prevalence of TTV Genotypes in HCC Patients in Egypt

Sample size: 90 publication Evidence: moderate

Author Information

Author(s): Hafez Mohamed M, Shaarawy Sabry M, Hassan Amr A, Salim Rabab F, Abd El Salam Fatma M, Ali Amal E

Primary Institution: National Cancer Institute, Cairo University

Hypothesis

The study aimed to assess the prevalence of TTV infection among Egyptian patients with liver cirrhosis and hepatocellular carcinoma.

Conclusion

TTV is commonly present in patients with HCC and LC, with genotype 1 being the most prevalent, but it does not contribute to the severity of liver disease or the causation of HCC.

Supporting Evidence

  • TTV DNA was found in 43.3% of the subjects studied.
  • The most prevalent TTV genotype was genotype 1, found in 35.7% of HCC patients.
  • 46.7% of HCC patients had TTV infection, compared to 40% of LC patients and 36.7% of healthy individuals.
  • Blood transfusion history was common among infected patients, with 75.1% of HCC patients with transfusion having TTV.

Takeaway

This study found that a lot of people with liver problems and even healthy people have a virus called TTV, but it doesn't seem to make their liver problems worse.

Methodology

The study analyzed serum samples from 60 patients with HCC and liver cirrhosis, and 30 healthy individuals, using nested-PCR to detect TTV DNA.

Limitations

The study's sample size was limited to 90 individuals, which may not represent the broader population.

Participant Demographics

The mean age of participants was 60.3 years for HCC patients, 53.2 years for LC patients, and 38.7 years for healthy individuals, with a mix of males and females.

Statistical Information

P-Value

> 0.05

Digital Object Identifier (DOI)

10.1186/1743-422X-4-135

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication